Suchergebnisse - "Immune Checkpoint Inhibitors"

Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancer.

Autoren: de Vries F Otten LS Piet B et al.

Körperschaften: de Vries F Otten LS Piet B et al.

Quelle: International journal of cancer [Int J Cancer] 2025 Dec 15; Vol. 157 (12), pp. 2569-2576. Date of Electronic Publication: 2025 Jul 24.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

MeSH-Schlagworte: Antibodies, Monoclonal, Humanized*/pharmacokinetics , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/blood , Lung Neoplasms*/drug therapy , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , Lung Neoplasms*/blood , Biomarkers, Tumor* , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacokinetics , Antineoplastic Agents, Immunological*/therapeutic use , Antineoplastic Agents, Immunological*/pharmacokinetics, Humans ; Female ; Male ; Prognosis ; Middle Aged ; Aged ; Disease Progression ; Aged, 80 and over ; Adult

Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter study.

Autoren: Yu N Chen C Wang X et al.

Quelle: International immunopharmacology [Int Immunopharmacol] 2025 Dec 10; Vol. 167, pp. 115666. Date of Electronic Publication: 2025 Oct 13.

Publikationsart: Journal Article; Multicenter Study

Info zur Zeitschrift: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

MeSH-Schlagworte: Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/pathology , Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/mortality , Esophageal Squamous Cell Carcinoma*/pathology , Esophageal Squamous Cell Carcinoma*/immunology , Chemoradiotherapy* , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/adverse effects , Consolidation Chemotherapy*/methods , Consolidation Chemotherapy*/adverse effects , Immunotherapy*/methods, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Progression-Free Survival ; Treatment Outcome

Can NaCl predict or even enhance responses to immunotherapy in cancer?

Autoren: Saal J Hölzel M Klümper N

Quelle: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Dec 09; Vol. 231, pp. 116057. Date of Electronic Publication: 2025 Oct 18.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

MeSH-Schlagworte: Neoplasms*/immunology , Neoplasms*/therapy , Neoplasms*/drug therapy , Neoplasms*/blood , Immunotherapy*/methods , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Sodium Chloride* , Sodium Chloride, Dietary*, Humans ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology ; Animals ; Treatment Outcome

LIMD2 is associated with an exhausted CD8⁺ T cell state linked to ICI response in clear cell renal cell carcinoma.

Autoren: Zhang J Peng Q Xiang X et al.

Quelle: Scientific reports [Sci Rep] 2025 Dec 04; Vol. 15 (1), pp. 43171. Date of Electronic Publication: 2025 Dec 04.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/immunology , Carcinoma, Renal Cell*/genetics , Carcinoma, Renal Cell*/pathology , Carcinoma, Renal Cell*/metabolism , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/immunology , Kidney Neoplasms*/pathology , Kidney Neoplasms*/genetics , Kidney Neoplasms*/metabolism , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , LIM Domain Proteins*/metabolism , LIM Domain Proteins*/genetics, Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Single-Cell Analysis ; Gene Expression Regulation, Neoplastic ; Male

Neoadjuvant Immune Checkpoint Inhibition in MSI-H/dMMR Colorectal Cancer: A Systematic Review of Prospective Trials Evaluating Efficacy, Pathologic Response, and Surgical Outcomes.

Autoren: Mirza W Khan ME Iqbal H et al.

Quelle: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2025 Dec 04; Vol. 56 (1), pp. 236. Date of Electronic Publication: 2025 Dec 04.

Publikationsart: Journal Article; Systematic Review; Review

Info zur Zeitschrift: Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/immunology , Neoadjuvant Therapy*/methods, Humans ; Microsatellite Instability ; DNA Mismatch Repair ; Prospective Studies ; Clinical Trials, Phase II as Topic ; Treatment Outcome

Management of MOG antibody-associated disease by pembrolizumab and radiation myelopathy in an elderly patient: A case report and literature review.

Autoren: Wang X Wang J Wu J et al.

Quelle: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2588020. Date of Electronic Publication: 2025 Nov 25.

Publikationsart: Journal Article; Case Reports; Review

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

MeSH-Schlagworte: Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Radiation Injuries*/drug therapy , Antineoplastic Agents, Immunological*/adverse effects , Antineoplastic Agents, Immunological*/therapeutic use, Humans ; Aged ; Female ; Esophageal Neoplasms/radiotherapy ; Esophageal Neoplasms/therapy ; Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Recent findings on the PD-1/PD-L1 Axis in breast cancer: Molecular mechanisms, immunotherapeutic potentials, and clinical implications.

Autoren: Ahmadi R Sadeghi KF Sharmsar O et al.

Quelle: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2025 Dec; Vol. 216, pp. 104989. Date of Electronic Publication: 2025 Oct 25.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

MeSH-Schlagworte: B7-H1 Antigen*/metabolism , B7-H1 Antigen*/antagonists & inhibitors , B7-H1 Antigen*/immunology , Programmed Cell Death 1 Receptor*/metabolism , Programmed Cell Death 1 Receptor*/antagonists & inhibitors , Programmed Cell Death 1 Receptor*/immunology , Breast Neoplasms*/metabolism , Breast Neoplasms*/therapy , Breast Neoplasms*/immunology , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Immunotherapy*/methods , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology, Humans ; Female ; Signal Transduction/drug effects ; Animals

Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma.

Autoren: Xue L Xu T Cao G et al.

Quelle: Cancer treatment reviews [Cancer Treat Rev] 2025 Dec; Vol. 141, pp. 103048. Date of Electronic Publication: 2025 Nov 12.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

MeSH-Schlagworte: Squamous Cell Carcinoma of Head and Neck*/drug therapy , Squamous Cell Carcinoma of Head and Neck*/immunology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/administration & dosage , Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/immunology , Antibodies, Monoclonal*/therapeutic use , Antibodies, Monoclonal*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/immunology ; Consensus

Adrenal Insufficiency-Induced Delirium Following Gastrectomy in a Patient With Gastric Cancer Treated With Nivolumab, Immune Checkpoint Inhibitors: A Case Report.

Autoren: Yamada K Sasaki T Owada T et al.

Quelle: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2025 Dec; Vol. 45 (4), pp. e70072.

Publikationsart: Case Reports; Journal Article

Info zur Zeitschrift: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101719700 Publication Model: Print Cited Medium: Internet ISSN: 2574-173X (Electronic) Linking ISSN: 2574173X NLM ISO Abbreviation: Neuropsychopharmacol Rep Subsets: MEDLINE

MeSH-Schlagworte: Adrenal Insufficiency*/complications , Adrenal Insufficiency*/drug therapy , Adrenal Insufficiency*/chemically induced , Adrenal Insufficiency*/diagnosis , Delirium*/etiology , Delirium*/drug therapy , Nivolumab*/adverse effects , Gastrectomy*/adverse effects , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/surgery , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Postoperative Complications*, Humans ; Female ; Aged ; Hydrocortisone/therapeutic use

From tumor immunotherapy to myocardial injury: A mechanistic discussion of immune checkpoint inhibitor‑related myocarditis (Review).

Autoren: Dai L Duan Y Xiong Q

Quelle: Molecular medicine reports [Mol Med Rep] 2025 Dec; Vol. 32 (6). Date of Electronic Publication: 2025 Oct 03.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-3004 (Electronic) Linking ISSN: 17912997 NLM ISO Abbreviation: Mol Med Rep Subsets: MEDLINE

MeSH-Schlagworte: Myocarditis*/chemically induced , Myocarditis*/etiology , Myocarditis*/diagnosis , Myocarditis*/immunology , Myocarditis*/pathology , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Immunotherapy*/adverse effects , Neoplasms*/immunology , Neoplasms*/therapy , Neoplasms*/drug therapy, Humans ; Animals

Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.

Autoren: Ye C Nikolic RPA Choi M et al.

Quelle: The Journal of rheumatology [J Rheumatol] 2025 Dec 01; Vol. 52 (12), pp. 1207-1217. Date of Electronic Publication: 2025 Dec 01.

Publikationsart: Journal Article; Practice Guideline; Systematic Review

Info zur Zeitschrift: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet ISSN: 1499-2752 (Electronic) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/adverse effects , Neoplasms*/drug therapy , Neoplasms*/immunology , Neoplasms*/complications , Rheumatic Diseases*/complications , Rheumatic Diseases*/drug therapy , Immunosuppression Therapy*, Humans ; Canada ; Rheumatology

Immune checkpoint inhibitor related myositis: an observational, retrospective, pharmacovigilance study.

Autoren: Yang H Ding Z An Z et al.

Quelle: Expert opinion on drug safety [Expert Opin Drug Saf] 2025 Dec; Vol. 24 (12), pp. 1415-1420. Date of Electronic Publication: 2024 Apr 24.

Publikationsart: Journal Article; Observational Study

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

MeSH-Schlagworte: Myositis*/chemically induced , Myositis*/epidemiology , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/administration & dosage, Humans ; Retrospective Studies ; Pharmacovigilance ; Male ; Female ; Middle Aged ; Aged ; Neoplasms/drug therapy ; Adult ; Age Factors ; Aged, 80 and over ; Risk Factors ; Adverse Drug Reaction Reporting Systems

Necrotizing and Nonnecrotizing Granulomatous Reactions in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic Literature Review.

Autoren: Wang EY Braverman G Ghosh N et al.

Quelle: The Journal of rheumatology [J Rheumatol] 2025 Dec 01; Vol. 52 (12), pp. 1200-1206. Date of Electronic Publication: 2025 Dec 01.

Publikationsart: Journal Article; Systematic Review; Review

Info zur Zeitschrift: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet ISSN: 1499-2752 (Electronic) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Granuloma*/chemically induced , Granuloma*/pathology , Neoplasms*/drug therapy, Humans ; Middle Aged ; Necrosis/chemically induced ; Male ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Female ; Aged

Risk factors and mechanisms of immune checkpoint inhibitor-related pneumonitis.

Autoren: Chen Y Xu L Zou S et al.

Quelle: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2564554. Date of Electronic Publication: 2025 Oct 12.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Pneumonia*/chemically induced , Pneumonia*/epidemiology , Pneumonia*/mortality , Pneumonia*/diagnosis , Pneumonia*/therapy , Pneumonia*/etiology , Neoplasms*/drug therapy, Humans ; Risk Factors ; Incidence

Integrating neutrophils, lymphocytes and eosinophils: development and validation of the NLE Index in ICI-treated metastatic melanoma.

Autoren: Açar FP Acar C Yüksel HÇ et al.

Quelle: Melanoma research [Melanoma Res] 2025 Dec 01; Vol. 35 (6), pp. 380-389. Date of Electronic Publication: 2025 Aug 29.

Publikationsart: Journal Article; Validation Study

Info zur Zeitschrift: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE

MeSH-Schlagworte: Melanoma*/drug therapy , Melanoma*/pathology , Neutrophils*/pathology , Eosinophils*/pathology , Lymphocytes*/pathology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Prognosis ; Aged, 80 and over ; Neoplasm Metastasis

Decreased appetite in cancer patients treated with immune checkpoint inhibitors (ICIs): The MOUSEION-012 systematic review and meta-analysis.

Autoren: Vitale E Rizzo A Maistrello L et al.

Quelle: Clinical nutrition ESPEN [Clin Nutr ESPEN] 2025 Dec; Vol. 70, pp. 591-603. Date of Electronic Publication: 2025 Nov 04.

Publikationsart: Journal Article; Systematic Review; Meta-Analysis

Info zur Zeitschrift: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101654592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4577 (Electronic) Linking ISSN: 24054577 NLM ISO Abbreviation: Clin Nutr ESPEN Subsets: MEDLINE

MeSH-Schlagworte: Neoplasms*/drug therapy , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Appetite*/drug effects , Malnutrition*/chemically induced, Humans ; Immunotherapy/adverse effects ; Observational Studies as Topic ; Randomized Controlled Trials as Topic ; Female ; Male

Hypophysitis Associated with Immune Checkpoint Inhibitors.

Autoren: Corsello A Paragliola RM Torino F et al.

Quelle: Endocrinology and metabolism clinics of North America [Endocrinol Metab Clin North Am] 2025 Dec; Vol. 54 (4), pp. 685-702. Date of Electronic Publication: 2025 Jul 25.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 8800104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-4410 (Electronic) Linking ISSN: 08898529 NLM ISO Abbreviation: Endocrinol Metab Clin North Am Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Hypophysitis*/chemically induced , Hypophysitis*/diagnosis , Neoplasms*/drug therapy , Neoplasms*/immunology, Humans ; Immunotherapy/adverse effects

Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy.

Autoren: Enssle S Sax A May P et al.

Quelle: Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2504244. Date of Electronic Publication: 2025 May 14.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/pharmacology , Immune Checkpoint Inhibitors*/therapeutic use , Melanoma*/immunology , Melanoma*/pathology , Melanoma*/genetics , Melanoma*/drug therapy, Humans ; Animals ; Mice ; Signal Transduction ; Pyroptosis/immunology ; Immunotherapy/methods ; DEAD Box Protein 58/metabolism ; Cell Line, Tumor ; Phosphate-Binding Proteins/metabolism ; Female ; Gasdermins ; Receptors, Immunologic

Immune checkpoint inhibitor-related thrombocytopenia: Current status and future perspectives.

Autoren: Zhang PF Ye XC Shi XQ et al.

Quelle: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2025 Dec; Vol. 216, pp. 104976. Date of Electronic Publication: 2025 Oct 02.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Thrombocytopenia*/chemically induced , Thrombocytopenia*/diagnosis , Thrombocytopenia*/therapy , Thrombocytopenia*/etiology , Neoplasms*/drug therapy , Neoplasms*/immunology, Humans

Effectiveness of immune checkpoint inhibitor therapy in thyroid cancer: A systematic review.

Autoren: Tasong J Sheldon R Clements A et al.

Quelle: Cancer treatment reviews [Cancer Treat Rev] 2025 Dec; Vol. 141, pp. 103042. Date of Electronic Publication: 2025 Oct 27.

Publikationsart: Journal Article; Systematic Review; Review

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

MeSH-Schlagworte: Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/pharmacology , Thyroid Neoplasms*/drug therapy , Thyroid Neoplasms*/immunology, Humans